Abstract
The investigations are based on the pre- and post-therapeutic data from 333 study patients. The following criteria of patient eligibility were applied:
-
1.
Primary diagnosis of AML between December 1, 1978, and September 30,1982, in study AML-BFM-78 and between December 1,1982, and September 30, 1986, in study AML-BFM-83
-
2.
Age between 0 and 17 years
-
3.
Prior cytotoxic treatment not exceeding two weeks
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Creutzig, U., Ritter, J., Schellong, G. (1990). Patients and Therapy. In: Creutzig, U., Ritter, J., Schellong, G. (eds) Acute Myelogenous Leukemia in Childhood. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75351-0_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-75351-0_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-52070-2
Online ISBN: 978-3-642-75351-0
eBook Packages: Springer Book Archive